ecteinascidin 743 has been researched along with vatalanib in 1 studies
Studies (ecteinascidin 743) | Trials (ecteinascidin 743) | Recent Studies (post-2010) (ecteinascidin 743) | Studies (vatalanib) | Trials (vatalanib) | Recent Studies (post-2010) (vatalanib) |
---|---|---|---|---|---|
660 | 102 | 404 | 276 | 42 | 98 |
Protein | Taxonomy | ecteinascidin 743 (IC50) | vatalanib (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Epidermal growth factor receptor | Homo sapiens (human) | 0.4577 | |
Platelet-derived growth factor receptor beta | Homo sapiens (human) | 0.2013 | |
Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.73 | |
Vascular endothelial growth factor receptor 1 | Homo sapiens (human) | 0.1192 | |
Vascular endothelial growth factor receptor 3 | Homo sapiens (human) | 0.1475 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.378 | |
Vascular endothelial growth factor receptor 2 | Danio rerio (zebrafish) | 0.49 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Apice, G; Bruni, GS; Caponigro, F; Iaffaioli, RV; Milano, A | 1 |
1 review(s) available for ecteinascidin 743 and vatalanib
Article | Year |
---|---|
Medical treatment of gastrointestinal stromal tumors: state of the art and future perspectives.
Topics: Antineoplastic Agents; Benzamides; Chemotherapy, Adjuvant; Dioxoles; Drug Resistance, Neoplasm; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Indoles; Neoadjuvant Therapy; Niacinamide; Oligonucleotides; Phthalazines; Piperazines; Proto-Oncogene Mas; Pyridines; Pyrimidines; Pyrroles; Sunitinib; Tetrahydroisoquinolines; Trabectedin | 2006 |